GLP-1 RA
PBAC to advise on GLP-1s for obesity
Medicines advisory body notes “unmet clinical need for obesity treatments”, following deliberations on equitable access to GLP-1s The Pharmaceutical Benefits Advisory Committee (PBAC) will respond to the Minister for Health, Disability and …
TGA updates product warning for GLP-1s
Product warnings across GLP-1 RA class of medications aligned on the potential risk of suicidal ideation Health professionals are being urged to monitor patients using glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for the emergence or …
Weight-loss drugs fatten CWH sales
GLP-1s help to elevate Chemist Warehouse sales growth in the first quarter of the 2026 financial year, Sigma chief says Strong business momentum seen in the final quarter of FY25 …
Eucalyptus to pull products from Priceline
Telehealth provider set to walk away from in-store sales, to cash-in on demand of GLP-1 RAs Eucalyptus plans to stop selling its Kin and Software products through Priceline and Woolworths, …